These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9207946)

  • 1. Structure-activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer.
    Suzuki T; Fukazawa N; San-nohe K; Sato W; Yano O; Tsuruo T
    J Med Chem; 1997 Jun; 40(13):2047-52. PubMed ID: 9207946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overcoming of multidrug resistance by a newly synthesized quinoline compound, MS-209].
    Naito M; Nakanishi O; Tsuruo T
    Nihon Rinsho; 1997 May; 55(5):1122-7. PubMed ID: 9155163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
    Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
    Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel multidrug resistance reversal agents.
    Berger D; Citarella R; Dutia M; Greenberger L; Hallett W; Paul R; Powell D
    J Med Chem; 1999 Jun; 42(12):2145-61. PubMed ID: 10377220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
    Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
    Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 7-oxo-7H-naphtho[1,2,3-de]quinoline derivatives as potential anticancer agents active on multidrug resistant cell lines.
    Dzieduszycka M; Bontemps-Gracz MM; Stefańska B; Martelli S; Piwkowska A; Arciemiuk M; Borowski E
    Bioorg Med Chem; 2006 May; 14(9):2880-6. PubMed ID: 16458007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D; Dekel Y; Melikhov D; Margalit R
    Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models.
    Naito M; Matsuba Y; Sato S; Hirata H; Tsuruo T
    Clin Cancer Res; 2002 Feb; 8(2):582-8. PubMed ID: 11839680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A; Seth K; Kalra N; Shukla Y
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
    Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
    Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives.
    Hayashi M; Koike K; Rho MC; Kuwano M; Kishiye T; Komiyama K
    Anticancer Drug Des; 2001; 16(4-5):255-60. PubMed ID: 12049484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
    Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
    Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine.
    Liang GW; Lu WL; Wu JW; Zhao JH; Hong HY; Long C; Li T; Zhang YT; Zhang H; Wang JC; Zhang X; Zhang Q
    Fundam Clin Pharmacol; 2008 Aug; 22(4):429-37. PubMed ID: 18705753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of some taxoids as multidrug resistance modulator.
    Hasegawa T; Bai J; Zhang S; Wang J; Matsubara J; Kawakami J; Tomida A; Tsuruo T; Hirose K; Sakai J; Kikuchi M; Abe M; Ando M
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1122-6. PubMed ID: 17239597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.